Filteren op Last updated date SelectNaVoorFrom - To Date Einddatum Deze week Deze maand Afgelopen week Afgelopen maand Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Laat dit veld leeg Filter Resultaten (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Laat dit veld leeg Restrictions in use of cyproterone due to meningioma risk 27 maart 2020Press releaseHumanReferrals Recommendations to restrict use of fosfomycin antibiotics 27 maart 2020Press releaseHumanReferrals No change is needed in use of direct oral anticoagulants following EMA-funded study 27 maart 2020Press releaseHumanMedicinesPharmacovigilanceReferrals Benefits of medicines containing combination of methocarbamol and paracetamol continue to outweigh risks 27 maart 2020Press releaseHumanMedicinesPharmacovigilanceReferrals Ten years of MUMS: 22 new veterinary medicines authorised for minor uses and minor species 25 maart 2020NewsVeterinaryVeterinary limited markets Global regulators map out data requirements for phase 1 COVID-19 vaccine trials 24 maart 2020Press releaseHumanCOVID-19MedicinesVaccines COVID-19: Beware of falsified medicines from unregistered websites 24 maart 2020Press releaseHumanCOVID-19Medicines Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic 20 maart 2020Press releaseHumanCOVID-19Clinical trialsResearch and developmentVaccines Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 17-18 March 2020 20 maart 2020Press releaseVeterinaryMedicines EMA Management Board – highlights of March 2020 meeting 20 maart 2020Press releaseCorporateClinical trialsGovernanceMaximum residue limitPharmacovigilance 1 … 91 92 93 94 95 Page 95 of 384 96 97 98 99 … 384
No change is needed in use of direct oral anticoagulants following EMA-funded study 27 maart 2020Press releaseHumanMedicinesPharmacovigilanceReferrals
Benefits of medicines containing combination of methocarbamol and paracetamol continue to outweigh risks 27 maart 2020Press releaseHumanMedicinesPharmacovigilanceReferrals
Ten years of MUMS: 22 new veterinary medicines authorised for minor uses and minor species 25 maart 2020NewsVeterinaryVeterinary limited markets
Global regulators map out data requirements for phase 1 COVID-19 vaccine trials 24 maart 2020Press releaseHumanCOVID-19MedicinesVaccines
COVID-19: Beware of falsified medicines from unregistered websites 24 maart 2020Press releaseHumanCOVID-19Medicines
Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic 20 maart 2020Press releaseHumanCOVID-19Clinical trialsResearch and developmentVaccines
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 17-18 March 2020 20 maart 2020Press releaseVeterinaryMedicines
EMA Management Board – highlights of March 2020 meeting 20 maart 2020Press releaseCorporateClinical trialsGovernanceMaximum residue limitPharmacovigilance